期刊文献+

鹿瓜多肽注射液对强直性脊柱炎患者血清Vaspin的影响 被引量:1

Effects of Lugua Polypeptide Injection on Serum Vaspin Levels in the Patients of Ankylosing Spondylitis
原文传递
导出
摘要 目的:观察鹿瓜多肽注射液对强直性脊柱炎(AS)患者血清内脏脂肪组织来源的丝氨酸蛋白酶抑制剂(visceraladipose tissue-derived serine protease inhibitor,Vaspin)水平的影响,阐明Vaspin在强直性脊柱炎发生过程中可能的作用机制。方法:采用酶联免疫法测定AS患者鹿瓜多肽注射液治疗前后血清Vaspin水平及炎症因子浓度,并分析血清Vaspin水平与炎症因子间的相互关系。结果:AS组血清Vaspin水平明显高于正常对照组(1.79±0.27vs.0.72±0.08μg/L,P<0.01)。AS组患者血清Vaspin水平与TNF-α及BASDAI呈正相关(r=0.454,P<0.05和r=0.328,P<0.01)。TNF-α是影响空腹血清Vaspin水平的独立相关因素。AS组经鹿瓜多肽注射液治疗后ESR、CRP、TNF-α、BAS-DAI及BASFI均显著降低(均P<0.01),血清Vaspin水平也显著降低(1.79±0.27vs.1.26±0.07μg/L,P<0.01)。结论:鹿瓜多肽注射液能有效抑制致炎性细胞因子产生,控制和延缓疾病活动,同时降低血清Vaspin水平。 Objective:To investigate the effects of lugua polypeptide injection on serum levels of visceral adipose tissue-derived serine protease inhibitor(Vaspin) in patients with ankylosing spondylitis(AS) and to clarify the probable mechanism of Vaspin in the happened of AS.Methods: Serum levels of Vaspin and inflammatory cytokines were measured by ELISA method in the patients of AS.The relationship between the levels of serum Vaspin and inflammatory cytokines were analyzed.Results:The fasting serum levels of Vaspin in the patients of AS group were significantly higher than healthy control group(1.79±0.27 vs.0.72±0.08μg/L,P0.01).And which was positive correlated with the levels of tumor necrosis factor alpha(TNF-α) and the scores of Bath AS Disease Activity Index(BASDAI)(r=0.454,P0.05 and r=0.328,P0.01).The TNF-α was an independent factor affecting fasting serum levels of Vaspin.The levels of TNF-α,erythrocyte sedimentation(ESR),and C-reactive protein(CRP) and the scores of BASDAI and Bath AS Functional Index(BASFI) were significantly decreased after lugua polypeptide injection treatment(all P0.01).Interestingly,the levels of serum Vaspin were also significantly decreased(1.79±0.27 vs.1.26±0.07 μg/L,P0.01).Conclusions: Lugua polypeptide injections can effectively inhibit the production of inflammatory cytokines,control or delay disease activity,and reduce serum levels of Vaspin.
出处 《中国中医骨伤科杂志》 CAS 2012年第2期17-19,共3页 Chinese Journal of Traditional Medical Traumatology & Orthopedics
关键词 脊柱炎/强直性 鹿瓜多肽注射液 VASPIN Lugua polypeptide injection Ankylosing spondylitis Visceral adipose tissue-derived serine protease inhibitor
  • 相关文献

参考文献10

  • 1BRAUM J,SIEPER J.Ankylosing spondylitis[J].Lancet,2007,369:1379-1390.
  • 2LAGO F,DIEGUEZ C,GOMEZ-REINO J,et al.Adipokines asemerging mediators of immune response and inflammation[J].NatClin Pract Rheumatol,2007,3(12):716-724.
  • 3SENOLT L,HOUSA D,VERNEROVA Z,et al.Resistin is abun-dantly present in rheumatoid arthritis synovial tissue,synovial flu-id,and elevated serum resistin reflects disease activity[J].AnnRheum Dis,2007,66:458-463.
  • 4BRENTANO F,SCHORR O,OSPELT C,et al.Pre-B cell colo-ny-enhancing factor/visfatin,a new marker of inflammation inrheumatoid arthritis with proinflammatory and matrix-degradingactivities[J].Arthritis Rheum,2007,56(9):2829-2839.
  • 5SENOLT L,POLANSKA M,FILKOVA M,et al.Vaspin andomentin:new adipokines differentially regulated at the site of in-flammation in rheumatoid arthritis[J].Ann Rheum Dis,2010,699(7):1410-1411.
  • 6许敬人,张春燕,李伟民,林研,茅惠明,郭琛军,陈翠玲.补肾通督方对强直性脊柱炎血清TNF-α及TGF-β_1水平的影响[J].中国中西医结合杂志,2008,28(12):1093-1095. 被引量:3
  • 7刘宏潇,冯兴华,何夏秀,张华东,周广军.补肾强脊颗粒治疗强直性脊柱炎疗效与安全性评价[J].中国中西医结合杂志,2006,26(5):403-406. 被引量:12
  • 8SEEGER J,ZIEGELMEIER M,BACHMANN A,et al.Serumlevels of the adipokine vaspin in relation to metabolic and renal pa-rameters[J].J Clin Endocrinol Metab,2008,93(1):247-251.
  • 9BAL A,UULU E,BAHAR G,et a1.Comparison of serum IL-1beta,sIL-2R,IL-6,and TNF-alpha levels with disease activityparameters in ankylosing spondylitis[J].Clin Rheumatol,2007,26(2):211-215.
  • 10DIBATTISTA J A,MARTEL-PELLETIER J,WOSU L O,eta1.Glucocorticoid receptor mediated inhibition of interleuk in-1stimulated neural metalloprotease synthesis in normal humanchondrocytes[J].J Clin Endoerinol Metab,1991,72(2):316-326.

二级参考文献16

  • 1张莉芸,黄烽.生物制剂治疗强直性脊柱炎研究进展[J].中华风湿病学杂志,2005,9(2):112-115. 被引量:50
  • 2许敬人,房敏,韩捷,林研,许淑敏,孙勤.强直性脊柱炎患者血清TNF-a、BGP和CTX水平与骨密度的关系[J].颈腰痛杂志,2006,27(3):170-172. 被引量:11
  • 3郑筱萸.中药新药临床研究指导原则[M].北京:中国中医药出版社,2001.68.
  • 4Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis 1993 ;52 ( 3 ) : 174--176.
  • 5Braun J, Sieper J. The sacroiliac joint in the spondyloarthropathies. Curr Opin Rheumatol 1996;8: 275--287.
  • 6Krug HE. Fibroblasts from mice with progressive ankylosis proliferate excessively in response to transforming growth fractor-beta 1. J InvestingMed 1998;46(4): 134--139.
  • 7Chan J, Villarreal G, Jin W, et al. Intra-articular gene transfer of TNFR. Mol Ther 2002 ;6(6) : 727.
  • 8Prud Homme GJ. Alter immune tolerance therapeutically: the power of negative thinking. J Leukocyte Biol 2004; 75 (4) : 586.
  • 9Garrett S,Jenkinson T,Whitelock H,et al.A new approach to defining disease status in AS:the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI).J Rheumatol 1994; 21 (12):2286-2291.
  • 10Calin A,Garrett S,Whitelock H,et al.A new approach to defining functional ability in ankylosing spondylitis:the development of the Bath Ankylosing Spondylitis Functional Index (BASFI).J Rheumatol 1994;21(12):2281-2285.

共引文献13

同被引文献19

引证文献1

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部